首页> Leukemia & lymphoma> Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.

Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marie-Anne,Couturier

第一单位： Department of Hematology, Hôpital Morvan, CHRU Brest, Brest, France.

作者： Marie-Anne,Couturier ^[1] ; Xavier,Thomas ^[2] ; Emmanuel,Raffoux ^[3] ; Françoise,Huguet ^[4] ; Céline,Berthon ^[5] ; Célestine,Simand ^[6] ; Maria-Pilar,Gallego-Hernanz ^[7] ; Yosr,Hicheri ^[8] ; Mathilde,Hunault Berger ^[9] ; Colombe,Saillard ^[10] ; Thibaut,Leguay ^[11] ; Clémence,Loiseau ^[12] ; Marie-Christine,Béné ^[13] ; Patrice,Chevallier ^[14]

作者单位： Department of Hematology, Hôpital Morvan, CHRU Brest, Brest, France. ^[1] Department of Hematology, Hôpital Lyon-Sud, Lyon, France. ^[2] Department of hematology, APHP St-Louis, Paris, France. ^[3] Department of Hematology, CHRU - Institut Universitaire de Cancer Toulouse - Oncopole, Toulouse, France. ^[4] Department of Hematology, Hôpital Claude Huriez, CHRU Lille, Lille cedex, France. ^[5] Department of Hematology, CHU de Hautepierre, Strasbourg, France. ^[6] Department of Hematology, CHU La Miletrie, Poitiers, France. ^[7] Department of Hematology, Hôpital Saint Eloi, CHRU Montpellier, Montpellier, France. ^[8] Department of Hematology, CHRU Angers, Angers, France. ^[9] Department of Hematology, Institut Paoli Calmettes, Marseille, France. ^[10] Department of Hematology, Hôpital Haut-Leveque, CHU Bordeaux, Bordeaux, France. ^[11] Department of Hematology Oncology, CH de Versailles, Hôpital André Mignot, Le Chesnay, France. ^[12] Department of Hematology/Biology, CHU Nantes, Nantes, France. ^[13] Department of Hematology, CHU Nantes, Nantes, France. ^[14]

关键词 Relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia blinatumomab ponatinib